Skip to main content
Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
27.66
-0.96 (-3.35%)
At close: Dec 23, 2024

BIOVF Revenue

Swedish Orphan Biovitrum AB had revenue of 6.89B SEK in the quarter ending September 30, 2024, with 33.40% growth. This brings the company's revenue in the last twelve months to 25.44B, up 19.58% year-over-year. In the year 2023, Swedish Orphan Biovitrum AB had annual revenue of 22.12B with 17.74% growth.

Revenue (ttm)
25.44B SEK
Revenue Growth
+19.58%
P/S Ratio
n/a
Revenue / Employee
14.35M SEK
Employees
1,772
Market Cap
9.65B USD

Revenue Chart

* This company reports financials in SEK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 201914.25B5.11B55.90%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sandoz Group AG 10.11B
Telix Pharmaceuticals Limited 430.80M
Elekta AB (publ) 1.66B
Ryman Healthcare Limited 458.44M
Verano Holdings Corp. 897.57M
Vireo Growth Inc. 98.53M
Medexus Pharmaceuticals Inc. 104.76M
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News